DARIEN, Conn., March 6, 2025 /PRNewswire/ -- CEFALY Technology, maker of the #1 neuromodulation treatment for migraine, announced today it has selected PayrHealth, the industry's leading Complete ...
DARIEN, Conn., June 28, 2022 /PRNewswire/ -- CEFALY Technology has partnered with Ordergroove, the leader in Relationship Commerce, to offer an upgraded electrode subscription experience to its ...
Cefaly is an external trigeminal nerve stimulation (eTNS) device used as a preventive treatment measure for migraine. It’s approved by the Food and Drug Administration (FDA), and it’s thought to work ...
DW Healthcare Partners (DWHP) has acquired a majority stake in Cefaly Technology SPRL, a Liège, Belgium-based maker and marketer of neuro-modulating medical devices for the prevention and treatment of ...
The FDA has approved Cefaly, a new type of device for migraine sufferers. Here’s everything you need to know about Cefaly. Cefaly is a special type of headband that is worn for 20 minutes per day.
TORONTO, Aug. 8, 2019 /PRNewswire/ — DW Healthcare Partners (“DWHP”), a healthcare-focused private equity firm, announced today a majority investment in CEFALY Technology SPRL (“CEFALY”), a leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results